Issued Patents All Time
Showing 51–75 of 83 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 6492516 | Compounds having cytokine inhibitory activity | David A. Claremon, Cory R. Theberge | 2002-12-10 |
| 6440976 | Iminopyrimidine NMDA NR2B receptor antagonists | David A. Claremon, John A. McCauley, Cory R. Theberge | 2002-08-27 |
| 6403596 | Substituted pyridones having cytokine inhibitory activity | David A. Claremon, John W. Butcher, Cory R. Theberge | 2002-06-11 |
| 6376530 | Cyclic amidines useful as NMDA NR2B antagonists | Christopher F. Claiborne, David A. Claremon | 2002-04-23 |
| 6319944 | Aryl amidines, compositions containing such compounds and methods of use | Christopher F. Claiborne, Brian Libby, Neil Roy Curtis, Janusz Kulagowski | 2001-11-20 |
| 6316474 | 2-benzyl and 2-heteroaryl benzimidazole NMDA/NR2B antagonists | John A. McCauley, Cory R. Theberge, David A. Claremon, Christopher F. Claiborne | 2001-11-13 |
| 6303637 | Heterocyclic potassium channel inhibitors | Jianming Bao, Andrew Kotliar, Frank Kayser, William H. Parsons, Kathleen M. Rupprecht +3 more | 2001-10-16 |
| 6291457 | Compounds having cytokine inhibitory activity | Christopher F. Claiborne, David A. Claremon, Kevin T. Nguyen | 2001-09-18 |
| 6214823 | Benzodiazepine derivatives as antiarrhythmic agents | John W. Butcher, David A. Claremon, Harold G. Selnick | 2001-04-10 |
| 6207687 | Substituted imidazoles having cytokine inhibitory activity | Christopher F. Claiborne, David A. Claremon | 2001-03-27 |
| 6194458 | Benzamide potassium channel inhibitors | Robert K. Baker, Jianming Bao, Frank Kayser, Andrew Kotliar, William H. Parsons +4 more | 2001-02-27 |
| 6083949 | Substituted imidazoles having anti-cancer and cytokine inhibitory activity | Christopher F. Claiborne, David A. Claremon, Harold G. Selnick | 2000-07-04 |
| 5859041 | Substituted imidazoles having cytokine inhibitory activity | David A. Claremon, John W. Butcher, Mark T. Bilodeau | 1999-01-12 |
| 5837719 | 2,5-substituted aryl pyrroles, compositions containing such compounds and methods of use | Stephen E. de Laszlo, Gerald S. Ponticello, Harold G. Selnick, Nathan B. Mantlo | 1998-11-17 |
| 5821241 | Fibrinogen receptor antagonists | David A. Claremon, John J. Baldwin, Ben C. Askew | 1998-10-13 |
| 5792778 | 2-substituted aryl pyrroles, compositions containing such compounds and methods of use | Stephen E. de Laszlo, Gerald S. Ponticello, Harold G. Selnick, Nathan B. Mantlo | 1998-08-11 |
| 5726171 | N-(1-alkyl-5-phenyl-2,3,4,5-tetrahydro-1H-benzoB!1,4!diazepi n-3yl)-acetamides | David A. Claremon, Garry Robert Smith, Harold G. Selnick | 1998-03-10 |
| 5717100 | Substituted imidazoles having anti-cancer and cytokine inhibitory activity | Harold G. Selnick, David A. Claremon | 1998-02-10 |
| 5700797 | N-(2,4-dioxo-2,3,4,5-tetrahydro-1H-1,5-benzodiazepin-3-yl)-3-amides | David A. Claremon, Harold G. Selnick | 1997-12-23 |
| 5696111 | 3-acylaminobenzazepines | John J. Baldwin, David A. Claremon, Harold G. Selnick | 1997-12-09 |
| 5691331 | N-(2,4-Dioxo-2,3,4,5-tetrahydro-1H-1,5-benzodiazepin-3yl) -3- amides | David A. Claremon, Roger M. Freidinger, Harold G. Selnick, Garry Robert Smith | 1997-11-25 |
| 5691332 | N-(2,4-dioxo-2,3,4,5-tetrahydro-1H-1,5-benzodiazepin-3-yl)-3-amides | David A. Claremon, Roger M. Freidinger, Harold G. Selnick, Garry Robert Smith | 1997-11-25 |
| 5679672 | Benzodiazepines | John J. Baldwin, David A. Claremon, Jason Matthew Elliott, David C. Remy, Harold G. Selnick | 1997-10-21 |
| 5658901 | 2,3-dihydro-1-(2,2,2,-trifluoroethyl)-2-oxo-5-phenyl-1H-1,4-benzo diazepines | David A. Claremon, Harold G. Selnick | 1997-08-19 |
| 5633251 | N-2,3-dihydro-1-(2-propyl)-2-oxo-5-phenyl-1h-1,4-benzodiazepines | David A. Claremon, Harold G. Selnick | 1997-05-27 |